DR. Verachai Lohavichan, M.D. is a nephrology internal medicine in Charlotte, NC with 28 years of experience. The provider is an internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation. DR. Verachai Lohavichan, M.D. NPI is 1568428159. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Graduation Year:1996
The provider's business location address is:
3158 FREEDOM DR STE 3101
CHARLOTTE, NC
ZIP 28208-014
Phone: (704) 348-2992
Fax: (704) 334-3061
The NPI 1568428159 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes (HCPCS:99152)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Fluoroscopic guidance for insertion, replacement or removal of central venous access device (HCPCS:77001)
- Moderate sedation services by physician also performing a procedure, additional 15 minutes (HCPCS:99153)
- Ultrasound guidance for accessing into blood vessel (HCPCS:76937)
- Hemodialysis procedure with one physician evaluation (HCPCS:90935)
- Dialysis services (4 or more physician visits per month), patient 20 years of age and older (HCPCS:90960)
The enumeration date for this NPI number is 4/24/2006 and was last updated on 7/7/2023.